首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 整形外科 > Biomet簡介(脊柱、創傷):全球地區別市場佔有率分析、SWOT分析、產品線及財務:2012年
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

Biomet簡介(脊柱、創傷):全球地區別市場佔有率分析、SWOT分析、產品線及財務:2012年

Biomet Profile (Spine & Trauma): Global Market Share Analysis by Region, SWOT, Product Pipeline & Financials 2012

出版商 iData Research Inc.
出版日期 2011年10月 商品編碼 220780
內容資訊 英文 81 Pages
價格
US $ 1995 Hard Copy
US $ 1995 PDF by E-mail (Single User License)
US $ 2995 PDF by E-mail (Corporate License)


Biomet簡介(脊柱、創傷):全球地區別市場佔有率分析、SWOT分析、產品線及財務:2012年 是由出版商iData Research Inc.在2011年10月所出版的。 這份英文市場調查報告書包含81 Pages 價格從美金1995起跳。

簡介

Biomet為全球五大整形外科植入體製造商之一,產品於美國、歐洲、亞洲及眾多新興市場等地銷售。運動醫學、牙科用醫療儀器等領域也拓展了其商業範圍。2011年目前,已於全球90個國家中銷售其產品,並有數十億美金之收益。

本報告為匯整Biomet公司之企業概要、業務內容、於全球脊柱、創傷市場中之市場佔有率及地位等,以下列摘要形式闡述。

目錄

圖表

第1章 實施概要

第2章 調查方式

第3章 Biomet企業概要

  • 簡介
  • 企業簡介
    • 業務部門
      • 整形外科重建
      • 整形外科創傷、脊柱、生物製劑
      • 運動醫學
      • 顱頜面
      • 牙科
  • 全球收益
    • 部門別
    • 地區別
  • 企業歷史
  • 企業資訊
    • 規模
    • 辦公室、據點

第4章 財務指標

  • 損益表
  • 資產負債表

第5章 產品線

  • 脊柱植入體
    • 提出美國FDA 510K
  • 整形外科創傷
    • 提出美國FDA 510K

第6章 SWOT分析

第7章 脊柱植入體之市場佔有率

  • 市場簡介
    • 簡介
      • 脊柱固定
      • 傳統椎體間固定
      • 低侵入式固定
      • 運動保持
      • 椎體壓縮性骨折
      • 電刺激
  • 主要產品
  • 市場佔有率收益分析
    • 脊柱植入體
      • 全球
      • 美國
      • 歐洲
      • 亞太地區

第8章 整形外科創傷市場佔有率

  • 市場簡介
    • 解剖及病理學
    • 治療概要
    • 內部固定
    • 外部固定
    • 長骨刺激
  • 主要產品
    • 螺旋板
    • 髖部骨折螺釘
    • 外部固定
  • 市場佔有率及收益分析
    • 外傷固定
      • 全球
      • 美國
      • 歐洲
      • 日本

縮寫

圖表

目錄

Abstract

Biomet is one of the five largest orthopedic implant manufacturers in the world, with distribution in the U.S., Europe, Asia and a number of emerging markets. Throughout its history, the company has also expanded into areas such as sports medicine and dental medical devices. As of 2011, Biomet distributed products in approximately 90 countries across the globe, earning revenues in the billions. This report is a comprehensive overview of Biomet's business activities with an in-depth analysis of the company's market share and presence in global spine and trauma markets.

The information covered includes:

  • An overview of the company history and current product divisions
  • A summary of corporate financial metrics
  • A review of recently approved products and the results of preliminary clinical trials
  • An in-depth review of the strengths, weaknesses opportunities and threats (SWOT) to the company's orthopedic biomaterials divisions
  • A detailed look at the market share and performance of each division in various countries across the U.S., Europe and Asia. Whenever possible, market share and division revenues are examined by individual country for each region of the globe.

The key product areas covered in this report include:

Internal Fixation:

  • Plates and Screws
  • Bioabsorbable Plates and Screws
  • Intramedullary Nails
  • Cannulated Screws
  • Conventional Hip Screws
  • Intramedullary Hip Screws
  • Pins, Wires and Cables

External Fixation

Long Bone Stimulators

The countries covered in this report include:

  • U.S.
  • Germany
  • France
  • U.K.
  • Spain
  • Italy
  • Benelux
  • Scandinavia
  • Switzerland
  • Austria
  • Portugal
  • Japan
  • Australia
  • South Korea

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

1. EXECUTIVE SUMMARY

  • 1.1. BIOMET OVERVIEW
  • 1.2. CORPORATE REVENUE GROWTH BY BUSINESS UNIT
  • 1.3. GLOBAL REVENUE BY REGION
  • 1.4. GLOBAL MARKET SHARE BY MARKET SIZE
  • 1.5. MARKET SHARE: SPINAL IMPLANTS
  • 1.6. MARKET SHARE: ORTHOPEDIC TRAUMA DEVICES

2. RESEARCH METHODOLOGY

  • 2.1. IDATA'S 9-STEP METHODOLOGY
    • 2.1.1. Step 1: Project Initiation & Team Selection
    • 2.1.2. Step 2: Prepare Data Systems and Perform Secondary Research
    • 2.1.3. Step 3: Preparation for Interviews & Questionnaire Design
    • 2.1.4. Step 4: Performing Primary Research
    • 2.1.5. Step 5: Research Analysis: Establishing Baseline Estimates
    • 2.1.6. Step 6: Market Forecast and Analysis
    • 2.1.7. Step 7: Identify Strategic Opportunities
    • 2.1.8. Step 8: Final Review and Market Release
    • 2.1.9. Step 9: Customer Feedback and Market Monitoring

3. BIOMET COMPANY OVERVIEW

  • 3.1. INTRODUCTION
  • 3.2. COMPANY PROFILE
    • 3.2.1. Business Units
      • 3.2.1.1. Orthopedic Reconstruction
      • 3.2.1.2. Orthopedic Trauma, Spine and Biologics
      • 3.2.1.3. Sports Medicine
      • 3.2.1.4. Craniomaxillofacial
        • 3.2.1.5. Dental
  • 3.3. GLOBAL REVENUES
    • 3.3.1. Global Revenues by Division
    • 3.3.2. Global Revenues by Geography
  • 3.4. COMPANY HISTORY
  • 3.5. COMPANY INFORMATION
    • 3.5.1. Size
    • 3.5.2. Office and Facility Locations

4. FINANCIAL METRICS

  • 4.1. INCOME STATEMENT
  • 4.2. BALANCE SHEET
    • 4.2.1. Balance Sheet
    • 4.2.2. Company Debt

5. PRODUCT PIPELINE

  • 5.1. SPINAL IMPLANTS
    • 5.1.1. U.S. FDA 510(k) Submissions
      • 5.1.1.1. Polaris™ Spinal System, Intervertebral
      • 5.1.1.2. Polaris™ Spinal System, Pedicle
      • 5.1.1.3. Zyston™ Arc Interbody Spacer
  • 5.2. ORTHOPEDIC TRAUMA
    • 5.2.1. U.S. FDA 510(k) Submissions
      • 5.2.1.1. Multi-Axial Correction (Mac) Male Adapter
      • 5.2.1.2. MaestroTM Wrist Plating System
      • 5.2.1.3. ExplorR Radial Head Plating System
      • 5.2.1.4. ComprehensiveTM Proximal Humeral Plating System

6. SWOT ANALYSIS

  • 6.1. SPINAL IMPLANTS AND TRAUMA FIXATION SWOT ANALYSIS
    • 6.1.1. Strengths
    • 6.1.2. Weaknesses
    • 6.1.3. Opportunities
    • 6.1.4. Threats

7. SPINAL IMPLANTS MARKET SHARE

  • 7.1. MARKET INTRODUCTION
    • 7.1.1. Introduction
      • 7.1.1.1. Spinal Fusion
      • 7.1.1.2. Traditional Interbody Fusion
        • 7.1.1.2.1. ALIF
        • 7.1.1.2.2. PLIF
        • 7.1.1.2.3. TLIF
        • 7.1.1.2.4. CIF
      • 7.1.1.3. Minimally Invasive Interbody Fusion
        • 7.1.1.3.1. Minimally Invasive TLIF (MITLIF)
        • 7.1.1.3.2. Minimally Invasive PLIF (MIPLIF)
        • 7.1.1.3.3. Lateral Lumbar Interbody Fusion (LLIF)
      • 7.1.1.4. Motion Preservation
        • 7.1.1.4.1. Artificial Discs
        • 7.1.1.4.2. Posterior Dynamic Stabilization
        • 7.1.1.4.3. Interspinous Process Decompression
        • 7.1.1.4.4. Nucleus Replacement
        • 7.1.1.4.5. Annular Repair
        • 7.1.1.4.6. Facet Arthroplasty
      • 7.1.1.5. Vertebral Compression Fracture (VCF)
      • 7.1.1.6. Electrical Stimulation
  • 7.2. KEY PRODUCTS
    • 7.2.1. Cervical
    • 7.2.2. Thoracolumbar
    • 7.2.3. Spacers
    • 7.2.4. Vertebroplasty
  • 7.3. MARKET SHARE AND REVENUE ANALYSIS
    • 7.3.1. Spinal Implants
      • 7.3.1.1. Global Market Share
      • 7.3.1.2. U.S. Market Share
      • 7.3.1.3. European Market Share
      • 7.3.1.4. Asia Pacific and Latin America

8. ORTHOPEDIC TRAUMA MARKET SHARE

  • 8.1. MARKET INTRODUCTION
    • 8.1.1. Anatomy and Pathology
      • 8.1.1.1. Anatomy
      • 8.1.1.2. Pathology and Healing
    • 8.1.2. Treatment Overview
      • 8.1.2.1. Internal Fixation
      • 8.1.2.2. External Fixation
      • 8.1.2.3. Bone Growth Stimulation
    • 8.1.3. Internal Fixation
      • 8.1.3.1. Plates and Screws
      • 8.1.3.2. Bioabsorbable Plates and Screws
      • 8.1.3.3. Intramedullary Nails
      • 8.1.3.4. Cannulated Screws
      • 8.1.3.5. Conventional Hip Screws
      • 8.1.3.6. Intramedullary Hip Screws
      • 8.1.3.7. Pins, Wires and Cables
    • 8.1.4. External Fixation
    • 8.1.5. Long Bone Stimulators
  • 8.2. KEY PRODUCTS
    • 8.2.1. Internal Plates and Screws
    • 8.2.2. Hip Fracture Screws
    • 8.2.3. Intramedullary Nails
    • 8.2.4. External Fixation
  • 8.3. MARKET SHARE AND REVENUE ANALYSIS
    • 8.3.1. Trauma Fixation
      • 8.3.1.1. Global Market Share
      • 8.3.1.2. United States Market Share
      • 8.3.1.3. European Market Share
      • 8.3.1.4. Japanese Market Share

ABBREVIATIONS

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

BIOMET COMPANY OVERVIEW

  • Figure 3-1: Global Revenues by Division, Biomet, (US$M), 2010 - 2011
  • Figure 3-2: Global Revenues Growth by Division, Biomet, 2011
  • Figure 3-3: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
  • Figure 3-4: Global Revenues by Geography, Biomet, (US$M), 2010 - 2011
  • Figure 3-5: Global Revenues by Geography, Biomet, 2011
  • Figure 3-6: Company Size, Biomet, 2011
  • Figure 3-7: Key Facilities, Biomet, 2011

FINANCIAL METRICS

  • Figure 4-1: Income Statement, Biomet, 2009 - 2011 (US$M)
  • Figure 4-2: Balance Sheet, Biomet, 2009 - 2011 (US$M)
  • Figure 4-3: Company Debt, Biomet, 2011 (US$M)

PRODUCT PIPELINE

SWOT ANALYSIS

SPINAL IMPLANTS MARKET SHARE

  • Figure 7-1: Spinal Implants Market Share, Biomet, 2011 (US$M)

ORTHOPEDIC TRAUMA MARKET SHARE

  • Figure 8-1: Orthopedic Trauma Market Share, Biomet, 2011 (US$M)

ABBREVIATIONS

LIST OF CHARTS

EXECUTIVE SUMMARY

  • Chart 1-1: Business Unit Revenue by Percentage, Biomet, 2011
  • Chart 1-2: Annual Revenue Growth by Business Unit, Biomet, 2011
  • Chart 1-3: Percentage of Global Revenues by Region, Biomet, 2011
  • Chart 1-4: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011
  • Chart 1-5: Spinal Implant Market Share, Biomet, 2011
  • Chart 1-6: Spinal Implant Market Share, Biomet, 2011

RESEARCH METHODOLOGY

BIOMET COMPANY OVERVIEW

  • Chart 3-1: Global Revenues by Division, Biomet, 2011
  • Chart 3-2: Global Revenue Growth by Division, Biomet, 2011
  • Chart 3-3: Global Market Share and Revenue Growth by Market Size, Biomet (US$M), 2011

FINANCIAL METRICS

PRODUCT PIPELINE

SWOT ANALYSIS

SPINAL IMPLANTS MARKET SHARE

  • Chart 7-1: Global Spinal Implants Market Share, Biomet, 2011
  • Chart 7-2: Spinal Implants Market Share by Region, Biomet, 2011

ORTHOPEDIC TRAUMA MARKET SHARE

  • Chart 8-1: Global Orthopedic Trauma Market Share, Biomet, 2011
  • Chart 8-2: Orthopedic Trauma Market Share by Region, Biomet, 2011

ABBREVIATIONS

Back to Top